Evolution of the immune response to chronic airway colonization with Aspergillus fumigatus hyphae

Infection and Immunity

Volumn 83, Issue 9, 2015, Pages 3590-3600

  Urb, Mirjam ^a   Snarr, Brendan D ^a   Wojewodka, Gabriella ^a   Lehoux, Mélanie ^a   Lee, Mark J ^a   Ralph, Benjamin ^a   Divangahi, Maziar ^a,b,c,d   King, Irah L ^a   McGovern, Toby K ^a,b   Martin, James G ^a,b   Fraser, Richard ^a   Radzioch, Danuta ^a   Sheppard, Donald C ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CXCL9 CHEMOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; FIBROBLAST GROWTH FACTOR 2; GALACTOMANNAN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHUS; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONIDIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; FUNGAL COLONIZATION; FUNGUS HYPHAE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; INFLAMMATION; LUNG ASPERGILLOSIS; LUNG HOMOGENATE; LUNG INFILTRATE; LYMPHOCYTIC INFILTRATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; ANIMAL; C57BL MOUSE; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; PATHOLOGY;

ANIMALS; ASPERGILLUS FUMIGATUS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HYPHAE; IMMUNOPHENOTYPING; MICE; MICE, INBRED C57BL; PULMONARY ASPERGILLOSIS; T-LYMPHOCYTE SUBSETS;

EID: 84939536221     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00359-15     Document Type: Article

References (43)

1. Hospenthal DR, Kwon-Chung KJ, Bennett JE. 1998. Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol 36:165-168.
2. Latge JP. 1999. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12:310-350.
3. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, Skov M, Maish W, Mastella G. 2003. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 37(Suppl 3):S225-S264. http://dx.doi.org/10.1086/376525.
4. Rapaka RR, Kolls JK. 2009. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med Mycol 47(Suppl 1):S331-S337. http://dx.doi.org/10.1080/13693780802266777.
5. Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, Hansel TT, Villiger B. 1994. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 150:1038-1048. http://dx.doi.org/10.1164/ajrccm.150.4.7921434.
6. Knutsen AP, Hutcheson PS, Mueller KR, Slavin RG. 1990. Serum immunoglobulins E and G anti-Aspergillus fumigatus antibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis. J Lab Clin Med 116:724-727.
7. Kurup VP, Banerjee B, Hemmann S, Greenberger PA, Blaser K, Crameri R. 2000. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 30:988-993. http://dx.doi.org/10.1046/j.1365-2222.2000.00837.x.
8. Chapman BJ, Capewell S, Gibson R, Greening AP, Crompton GK. 1989. Pulmonary eosinophilia with and without allergic bronchopulmonary aspergillosis. Thorax 44:919-924. http://dx.doi.org/10.1136/thx.44.11.919.
9. Shoseyov D, Brownlee KG, Conway SP, Kerem E. 2006. Aspergillus bronchitis in cystic fibrosis. Chest 130:222-226. http://dx.doi.org/10.1378/chest.130.1.222.
10. Kurup VP, Seymour BW, Choi H, Coffman RL. 1994. Particulate Aspergillus fumigatus antigens elicit a TH2 response in BALB/c mice. J Allergy Clin Immunol 93:1013-1020. http://dx.doi.org/10.1016/S0091-6749(94)70050-8.
11. Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. 1997. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185:1089-1099. http://dx.doi.org/10.1084/jem.185.6.1089.
12. Kurup VP, Guo J, Murali PS, Choi H, Fink JN. 1997. Immunopathologic responses to Aspergillus antigen in interleukin-4 knockout mice. J Lab Clin Med 130:567-575. http://dx.doi.org/10.1016/S0022-2143(97)90106-2.
13. Kurup VP, Murali PS, Guo J, Choi H, Banerjee B, Fink JN, Coffman RL. 1997. Anti-interleukin (IL)-4 and -IL-5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens. Allergy 52:1215-1221. http://dx.doi.org/10.1111/j.1398-9995.1997.tb02526.x.
14. Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, Rennick DM, Locksley RM. 1998. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 4:344-355. http://dx.doi.org/10.1007/s008940050092.
15. Guilbault C, Martin P, Houle D, Boghdady ML, Guiot MC, Marion D, Radzioch D. 2005. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Lab Anim 39:336-352. http://dx.doi.org/10.1258/0023677054306944.
16. Nawada R, Amitani R, Tanaka E, Niimi A, Suzuki K, Murayama T, Kuze F. 1996. Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection. J Clin Microbiol 34:1433-1439.
17. Liu H, Gravelat FN, Chiang LY, Chen D, Vanier G, Ejzykowicz DE, Ibrahim AS, Nierman WC, Sheppard DC, Filler SG. 2010. Aspergillus fumigatus AcuM regulates both iron acquisition and gluconeogenesis. Mol Microbiol 78:1038-1054. http://dx.doi.org/10.1111/j.1365-2958.2010.07389.x.
18. Sheppard DC, Marr KA, Fredricks DN, Chiang LY, Doedt T, Filler SG. 2006. Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis. Clin Microbiol Infect 12:376-380. http://dx.doi.org/10.1111/j.1469-0691.2005.01349.x.
19. Al-Bader N, Vanier G, Liu H, Gravelat FN, Urb M, Hoareau CM, Campoli P, Chabot J, Filler SG, Sheppard DC. 2010. Role of trehalose biosynthesis in Aspergillus fumigatus development, stress response, and virulence. Infect Immun 78:3007-3018. http://dx.doi.org/10.1128/IAI.00813-09.
20. Hogaboam CM, Blease K, Mehrad B, Steinhauser ML, Standiford TJ, Kunkel SL, Lukacs NW. 2000. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 156:723-732. http://dx.doi.org/10.1016/S0002-9440(10)64775-X.
21. Kurup VP, Mauze S, Choi H, Seymour BW, Coffman RL. 1992. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol 148:3783-3788.
22. Bosken CH, Myers JL, Greenberger PA, Katzenstein AL. 1988. Pathologic features of allergic bronchopulmonary aspergillosis. Am J Surg Pathol 12:216-222. http://dx.doi.org/10.1097/00000478-198803000-00007.
23. Murdock BJ, Shreiner AB, McDonald RA, Osterholzer JJ, White ES, Toews GB, Huffnagle GB. 2011. Coevolution of Th1, Th2, and Th17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect Immun 79:125-135. http://dx.doi.org/10.1128/IAI.00508-10.
24. Hoselton SA, Samarasinghe AE, Seydel JM, Schuh JM. 2010. An inhalation model of airway allergic response to inhalation of environmental Aspergillus fumigatus conidia in sensitized BALB/c mice. Med Mycol 48:1056-1065. http://dx.doi.org/10.3109/13693786.2010.485582.
25. Hohl TM, Van Epps HL, Rivera A, Morgan LA, Chen PL, Feldmesser M, Pamer EG. 2005. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 1:e30. http://dx.doi.org/10.1371/journal.ppat.0010030.
26. Fontaine T, Delangle A, Simenel C, Coddeville B, van Vliet SJ, van Kooyk Y, Bozza S, Moretti S, Schwarz F, Trichot C, Aebi M, Delepierre M, Elbim C, Romani L, Latge JP. 2011. Galactosaminogalactan, a new immunosuppressive polysaccharide of Aspergillus fumigatus. PLoS Pathog 7:e1002372. http://dx.doi.org/10.1371/journal.ppat.1002372.
27. Gravelat FN, Beauvais A, Liu H, Lee MJ, Snarr BD, Chen D, Xu W, Kravtsov I, Hoareau CM, Vanier G, Urb M, Campoli P, Al Abdallah Q, Lehoux M, Chabot JC, Ouimet MC, Baptista SD, Fritz JH, Nierman WC, Latge JP, Mitchell AP, Filler SG, Fontaine T, Sheppard DC. 2013. Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal beta-glucan from the immune system. PLoS Pathog 9:e1003575. http://dx.doi.org/10.1371/journal.ppat.1003575.
28. Gravelat FN, Doedt T, Chiang LY, Liu H, Filler SG, Patterson TF, Sheppard DC. 2008. In vivo analysis of Aspergillus fumigatus developmental gene expression determined by real-time reverse transcription-PCR. Infect Immun 76:3632-3639. http://dx.doi.org/10.1128/IAI.01483-07.
29. Shreiner AB, Murdock BJ, Sadighi Akha AA, Falkowski NR, Christensen PJ, White ES, Hogaboam CM, Huffnagle GB. 2012. Repeated exposure to Aspergillus fumigatus conidia results in CD4+ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1/Th2/Th17 microenvironment that requires interleukin-4 (IL-4) and IL-10. Infect Immun 80:388-397. http://dx.doi.org/10.1128/IAI.05530-11.
30. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299-311. http://dx.doi.org/10.1084/jem.20081463.
31. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, Belladonna ML, Vacca C, Conte C, Mosci P, Bistoni F, Puccetti P, Kastelein RA, Kopf M, Romani L. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37:2695-2706. http://dx.doi.org/10.1002/eji.200737409.
32. Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, Schwiebert LM, Faro-Trindade I, Brown GD, Steele C. 2009. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 182:4938-4946. http://dx.doi.org/10.4049/jimmunol.0804250.
33. Taylor PR, Leal SM, Jr, Sun Y, Pearlman E. 2014. Aspergillus and Fusarium corneal infections are regulated by Th17 cells and IL-17-producing neutrophils. J Immunol 192:3319-3327. http://dx.doi.org/10.4049/jimmunol.1302235.
34. Krishnamoorthy N, Khare A, Oriss TB, Raundhal M, Morse C, Yarlagadda M, Wenzel SE, Moore ML, Peebles RS, Jr, Ray A, Ray P. 2012. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat Med 18:1525-1530. http://dx.doi.org/10.1038/nm.2896.
35. Jiang H, Wu X, Zhu H, Xie Y, Tang S, Jiang Y. 2015. FOXP3(+)Treg/ Th17 cell imbalance in lung tissues of mice with asthma. Int J Clin Exp Med 8:4158-4163.
36. Regamey N, Tsartsali L, Hilliard TN, Fuchs O, Tan HL, Zhu J, Qiu YS, Alton EW, Jeffery PK, Bush A, Davies JC. 2012. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax 67:164-170. http://dx.doi.org/10.1136/thoraxjnl-2011-200585.
37. Skov M, McKay K, Koch C, Cooper PJ. 2005. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy. Respir Med 99:887-893. http://dx.doi.org/10.1016/j.rmed.2004.11.018.
38. Becker JW, Burke W, McDonald G, Greenberger PA, Henderson WR, Aitken ML. 1996. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 109:1536-1540. http://dx.doi.org/10.1378/chest.109.6.1536.
39. Schwartz RH, Hollick GE. 1981. Allergic bronchopulmonary aspergillosis with low serum immunoglobulin E. J Allergy Clin Immunol 68:290-294. http://dx.doi.org/10.1016/0091-6749(81)90154-8.
40. Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC. 2011. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 184:252-258. http://dx.doi.org/10.1164/rccm.201102-0236OC.
41. McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, Finder JD, Pilewski JM, Carreno BM, Goldman SJ, Pirhonen J, Kolls JK. 2005. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growthrelated oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 175:404-412. http://dx.doi.org/10.4049/jimmunol.175.1.404.
42. Kreindler JL, Steele C, Nguyen N, Chan YR, Pilewski JM, Alcorn JF, Vyas YM, Aujla SJ, Finelli P, Blanchard M, Zeigler SF, Logar A, Hartigan E, Kurs-Lasky M, Rockette H, Ray A, Kolls JK. 2010. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest 120:3242-3254. http://dx.doi.org/10.1172/JCI42388.
43. Zander DS. 2005. Allergic bronchopulmonary aspergillosis: an overview. Arch Pathol Lab Med 129:924-928.